Nancy Shen
About Nancy Shen
Nancy Shen is a Sr. Manager, Biomarker Operations at BeiGene and the Global Companion Diagnostics Lead at Amgen, with extensive experience in diagnostic testing and companion diagnostics development.
Title
Nancy Shen holds the position of Sr. Manager, Biomarker Operations at BeiGene and serves as the Global Companion Diagnostics Lead at Amgen in Thousand Oaks, California, United States.
Experience at Amgen
Nancy Shen has extensive experience at Amgen, where she initially worked as a Sr Associate Scientist from 1997 to 2016 for a duration of 19 years. Currently, she is the Global Companion Diagnostics Lead, where she provides both strategic and tactical support for companion diagnostic (CDx) development. Her role involves deploying her broad expertise in multiple diagnostic technologies, such as PCR, IHC, and Immunoassays.
Education and Expertise
Nancy Shen holds a Master’s Degree in Biochemistry from New York Medical College, which she earned between 1994 and 1996. She also has a Bachelor of Science (B.S.) in Molecular Biology from the University of California, Berkeley, completed between 1987 and 1991. Her educational background provides a strong foundation for her extensive expertise in molecular and companion diagnostics, including regulatory, commercial, and scientific/clinical development.
Specialist in Diagnostic Technologies
Nancy Shen is well-versed in various diagnostic technologies, particularly PCR, IHC, and Immunoassays. Her role in both BeiGene and Amgen involves leveraging these technologies to develop and implement diagnostic testing within clinical trials across multiple therapeutic areas, showcasing her broad functional capacity in this specialized field.